PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 70 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

30 July 2024

  1. (diff | hist) 10:28 Wuhan Wansheng Biotechnology 3,621 +722 GroupBuyGalen (talk | contribs) fix indentation in the source [rollback]
  2. (diff | hist) m b 01:19 Reconstitution of lyophilised peptides 2,816 +745 StubSorterBot (talk | contribs) bot: sort category members [rollback]

29 July 2024

  1. (diff | hist) m 22:05 Fmoc chemistry 1,950 ±0 FormularyFrida (talk | contribs) add the excursion tolerance with the study it derives from [rollback]
  2. (diff | hist) m 17:56 Enteroendocrine L cell 2,224 ±0 DPP4_Dagmar (talk | contribs) the numbers in the lead disagreed with the body; body was right [rollback]
  3. (diff | hist) 15:20 Retatrutide 2,444 ±0 FmocFrancis (talk | contribs) fix indentation in the source [rollback]
  4. (diff | hist) m 14:32 Insulin syringe 2,083 ±0 MicrodoseMagnus (talk | contribs) add the note that a smaller diluent volume raises concentration, not dose [rollback]
  5. (diff | hist) 13:57 Glossary of peptide terminology 2,033 ±0 LedeLeander (talk | contribs) expand §Clinical and evidence [rollback]
  6. (diff | hist) N 12:52 Insulin syringe 2,083 +2,083 RotationRosalind (talk | contribs) new article: dosing and handling, expansion welcome

28 July 2024

  1. (diff | hist) 23:55 Proglucagon 2,238 +370 DrTitration (talk | contribs) add the cleavage site by residue number [rollback]
  2. (diff | hist) 08:44 Analytical method validation 1,373 ±0 DiluentDiya (talk | contribs) de-duplicate a repeated sentence [rollback]
  3. (diff | hist) m b 06:50 Bacteriostatic water 2,332 +482 StubSorterBot (talk | contribs) bot: repair redlinked category [rollback]

27 July 2024

  1. (diff | hist) 20:30 Glucagon 2,758 ±0 ComparisonCato (talk | contribs) add the discontinued indication with its date [rollback]
  2. (diff | hist) 09:12 Tirzepatide 2,796 +615 GlossaryGaspar (talk | contribs) the storage condition applies to the unopened pen; say so [rollback]
  3. (diff | hist) 05:05 Reference standard 1,997 ±0 GroupBuyGalen (talk | contribs) correct the resolution formula — the denominator is the sum of the widths [rollback]
  4. (diff | hist) m b 01:00 Glucose-dependent insulinotropic polypeptide 3,368 +817 StubSorterBot (talk | contribs) bot: flag bare reference [rollback]

26 July 2024

  1. (diff | hist) m 15:28 WuXi TIDES 1,776 ±0 Hedgerow_Hal (talk | contribs) expand §Reception [rollback]
  2. (diff | hist) 13:00 Dual incretin agonist 2,297 ±0 OralSemaOswin (talk | contribs) add CAS number, sourced [rollback]
  3. (diff | hist) N 09:00 Haemoglobin A1c 1,274 +1,274 MissedDoseMik (talk | contribs) create article — laboratory stub
  4. (diff | hist) 00:32 Cold chain 5,166 +38 SupplyWatchSuri (talk | contribs) add category for logistics [rollback]

25 July 2024

  1. (diff | hist) m b 23:16 Adverse effects of GLP-1 receptor agonists 2,045 ±0 StubSorterBot (talk | contribs) bot: expand PMID to full citation [rollback]
  2. (diff | hist) 21:35 Vial 3,923 +650 TSH_Tallulah (talk | contribs) ce, tighten prose [rollback]
  3. (diff | hist) 15:58 Lot traceability 1,389 ±0 NPOV_Nadia (talk | contribs) correct the description of how lot identifiers are assigned [rollback]
  4. (diff | hist) 13:40 Third-party testing 2,441 +535 Peptide_Pete (talk | contribs) correct the description of how lot identifiers are assigned [rollback]
  5. (diff | hist) 00:47 Glucagon 2,758 +1,113 MissedDoseMik (talk | contribs) correct the molar mass — source gives the free-base figure, we had the salt [rollback]

24 July 2024

  1. (diff | hist) m 23:39 Peptide synthesis 2,347 +311 Chromatokid (talk | contribs) add the shelf temperature and the primary drying step to the cycle description [rollback]
  2. (diff | hist) 19:03 Lot traceability 1,389 ±0 BlindSampleBrid (talk | contribs) add the cross-link to the traceability article [rollback]
  3. (diff | hist) 15:16 Timeline of incretin therapeutics 1,103 ±0 INN_Ingrid (talk | contribs) expand §First-generation drugs [rollback]
  4. (diff | hist) N 09:00 Analytical method validation 1,373 +1,373 MassSpecMarv (talk | contribs) new article: analytical method, expansion welcome
  5. (diff | hist) m 07:58 Karl Fischer titration 2,412 ±0 TirzTaxonomist (talk | contribs) give the limit of quantitation with the signal-to-noise ratio it assumes [rollback]
  6. (diff | hist) 01:32 GLP-1 receptor agonist 2,788 ±0 NPOV_Nadia (talk | contribs) state the substitution in one-letter code as well, per PP:MOS [rollback]
  7. (diff | hist) 00:34 SURPASS trial programme 1,200 ±0 ArchiveAudit (talk | contribs) add category for the trial programme [rollback]

23 July 2024

  1. (diff | hist) 22:41 Guangzhou JEEP Biotechnology 2,753 +38 BlindSampleBrid (talk | contribs) expand §Regulatory position and legal status [rollback]
  2. (diff | hist) 19:17 STEP trial programme 2,343 ±0 SecretagogueSol (talk | contribs) serial comma per PP:MOS [rollback]
  3. (diff | hist) 15:52 Mass spectrometry 2,090 ±0 DiluentDiya (talk | contribs) add the equilibration time to the gradient description [rollback]
  4. (diff | hist) 11:32 High-performance liquid chromatography 2,620 ±0 Chromatokid (talk | contribs) add the peptide-content point: area percent alone cannot give a mass [rollback]
  5. (diff | hist) N 09:00 Vial 3,273 +3,273 CounterfeitCato (talk | contribs) create article — process stub
  6. (diff | hist) m b 04:19 Semaglutide 3,178 ±0 StubSorterBot (talk | contribs) bot: add drug-class category [rollback]
  7. (diff | hist) 01:17 Peptide 2,306 ±0 RotationRosalind (talk | contribs) add the customs-detention point as a logistics fact, sourced [rollback]

22 July 2024

  1. (diff | hist) m 22:03 Dipeptidyl peptidase-4 2,323 ±0 SatietySunniva (talk | contribs) add the reference range with the assay it was established on [rollback]
  2. (diff | hist) 17:29 Enteroendocrine L cell 2,224 +321 EmptyingElke (talk | contribs) correct the direction of the effect on gastric emptying [rollback]
  3. (diff | hist) N 09:00 Dual incretin agonist 2,297 +2,297 MazdutideMads (talk | contribs) new article: compound, expansion welcome
  4. (diff | hist) 03:15 GLP-1 receptor 3,125 ±0 SafetySignalSid (talk | contribs) expand §Genetic variation [rollback]

21 July 2024

  1. (diff | hist) 16:16 Glucagon-like peptide-1 3,812 +807 EndpointEnid (talk | contribs) state that the enzyme inhibitor class works by raising endogenous levels [rollback]
  2. (diff | hist) 13:59 Glossary of peptide terminology 2,033 +1,004 ReaderRosalie (talk | contribs) expand §Analysis and documentation [rollback]
  3. (diff | hist) m 11:07 Janoshik Analytical 2,054 +764 LedgerLysander (talk | contribs) add the turnaround time the service publishes [rollback]
  4. (diff | hist) N 09:00 SURPASS trial programme 1,200 +1,200 DataTableDunja (talk | contribs) start article; endpoints and registration only
  5. (diff | hist) 07:11 WuXi TIDES 1,776 ±0 MelanocortinMil (talk | contribs) fix the anchor on an internal link [rollback]
  6. (diff | hist) N 05:45 WuXi TIDES 1,776 +1,776 VerifyFirstVida (talk | contribs) new article: supplier organisation, created after the notability discussion

20 July 2024

  1. (diff | hist) 12:32 Proglucagon 1,868 ±0 ColdChainCleo (talk | contribs) space between number and unit per PP:MOS [rollback]
  2. (diff | hist) m 11:30 Reverse-phase HPLC 2,305 ±0 ForestPlotFinn (talk | contribs) add the plate-count expression and define its terms [rollback]

19 July 2024

  1. (diff | hist) N 09:00 Timeline of incretin therapeutics 1,103 +1,103 ComparisonCato (talk | contribs) start article on the compound
  2. (diff | hist) 08:58 Tirzepatide 2,181 ±0 AxisLabelAgda (talk | contribs) move a stray full stop inside the reference [rollback]
  3. (diff | hist) 03:52 Reconstitution of lyophilised peptides 2,071 ±0 HypoHildur (talk | contribs) expand §Mechanics [rollback]

18 July 2024

  1. (diff | hist) 14:52 Bacteriostatic water 1,850 ±0 FmocFrancis (talk | contribs) ce, tighten prose [rollback]
  2. (diff | hist) 12:29 Karl Fischer titration 2,412 +761 TechnicianTeal (talk | contribs) add short description [rollback]
  3. (diff | hist) 03:53 SUSTAIN trial programme 1,214 ±0 NNT_Nerys (talk | contribs) add the number randomised and the number completing [rollback]
  4. (diff | hist) N 00:27 Glucagon 1,645 +1,645 ShortDescShai (talk | contribs) start article on the compound

17 July 2024

  1. (diff | hist) 20:06 Incretin effect 2,353 ±0 ProglucagonPia (talk | contribs) clarify that the incretin effect is defined by the oral–intravenous comparison [rollback]
  2. (diff | hist) m b 19:54 Fmoc chemistry 1,950 +436 ArchiveBot (talk | contribs) bot: normalise unit spacing [rollback]
  3. (diff | hist) 16:40 Solid-phase peptide synthesis 1,893 ±0 PrepHPLC_Pia (talk | contribs) add the crimp-seal step to the fill-and-finish description [rollback]
  4. (diff | hist) N 10:38 SUSTAIN trial programme 1,214 +1,214 SurrogateSunday (talk | contribs) create article — trial programme stub
  5. (diff | hist) m 09:01 Retatrutide 2,444 +54 Chromatokid (talk | contribs) expand §Safety signals reported to date [rollback]
  6. (diff | hist) N 09:00 Lot traceability 1,389 +1,389 TelehealthTruus (talk | contribs) create article — testing stub

16 July 2024

  1. (diff | hist) m 21:08 Third-party testing 1,906 ±0 SupplyWatchSuri (talk | contribs) split overlong sentence [rollback]
  2. (diff | hist) N 16:03 Glossary of peptide terminology 1,029 +1,029 MolarMassMaeve (talk | contribs) start the list; inclusion criterion in the lead
  3. (diff | hist) m 10:33 Cold chain 5,128 ±0 GradientGus (talk | contribs) expand §Records and regulatory framing [rollback]
  4. (diff | hist) 07:35 Wuhan Wansheng Biotechnology 2,899 +38 COA_Colwyn (talk | contribs) add the registered legal name exactly as it appears in the registry record [rollback]
  5. (diff | hist) 03:21 Janoshik Analytical 1,290 ±0 PrimarySrcPatia (talk | contribs) add the note on how to request a batch record rather than a certificate [rollback]

15 July 2024

  1. (diff | hist) m 21:19 Adverse effects of GLP-1 receptor agonists 2,045 ±0 HypoHildur (talk | contribs) convert the adverse-event list to a table with both arms [rollback]
  2. (diff | hist) 08:59 Mass spectrometry 2,090 ±0 SigFigSindri (talk | contribs) expand §Ionisation and mass analysis [rollback]
  3. (diff | hist) m b 05:41 Reference standard 1,997 +808 CategoryBot (talk | contribs) bot: normalise citation format [rollback]

14 July 2024

  1. (diff | hist) 20:18 GL Biochem (Shanghai) 2,837 ±0 LotTraceLuka (talk | contribs) expand the product-scope row in the infobox [rollback]
  2. (diff | hist) m 00:48 Fmoc chemistry 1,514 ±0 DisparityDagny (talk | contribs) state that overlay gas is used and name it [rollback]

13 July 2024

  1. (diff | hist) m 22:25 Peptide synthesis 2,036 ±0 StateBoardStace (talk | contribs) copyedit [rollback]
  2. (diff | hist) 17:56 GLP-1 receptor agonist 2,788 ±0 FiveOhThreeB (talk | contribs) the half-life in the lead was the terminal figure; label it as such [rollback]
  3. (diff | hist) m 17:28 Guangzhou JEEP Biotechnology 2,715 ±0 BlindSampleBrid (talk | contribs) state the city and province of the registered address [rollback]
  4. (diff | hist) 06:33 STEP trial programme 2,343 ±0 DataTableDunja (talk | contribs) add the missing-data handling method [rollback]

12 July 2024

  1. (diff | hist) m 15:35 Enteroendocrine L cell 1,903 ±0 MazdutideMads (talk | contribs) convert the receptor-distribution list to a table [rollback]
  2. (diff | hist) 03:35 Glucose-dependent insulinotropic polypeptide 2,551 ±0 Chromatokid (talk | contribs) correct the second-messenger pathway named in the lead [rollback]
  3. (diff | hist) 01:17 Reverse-phase HPLC 2,305 +958 ResolutionRoo (talk | contribs) add the ionisation mode to the mass-spectrometry description [rollback]

11 July 2024

  1. (diff | hist) m 16:16 Peptide 2,306 +325 CDMO_Caradoc (talk | contribs) add the excursion tolerance with the study it derives from [rollback]
  2. (diff | hist) 15:55 Solid-phase peptide synthesis 1,893 ±0 MolarMassMaeve (talk | contribs) expand §Difficult sequences [rollback]
  3. (diff | hist) N 11:57 Janoshik Analytical 1,290 +1,290 CheckSumChase (talk | contribs) start article on the testing subject
  4. (diff | hist) m b 07:57 GLP-1 receptor 3,125 +294 StubSorterBot (talk | contribs) bot: sort category members [rollback]
  5. (diff | hist) m 02:48 Reconstitution of lyophilised peptides 2,071 ±0 SharpsSukhi (talk | contribs) add category for preparation and handling [rollback]

10 July 2024

  1. (diff | hist) N 23:55 Guangzhou JEEP Biotechnology 2,715 +2,715 COA_Colwyn (talk | contribs) create organisation article per PP:VN
  2. (diff | hist) 15:18 Glucagon-like peptide-1 3,005 ±0 Chromatokid (talk | contribs) serial comma per PP:MOS [rollback]
  3. (diff | hist) 06:25 Reverse-phase HPLC 1,347 ±0 DiluentDiya (talk | contribs) add the note on co-elution and what it hides [rollback]
  4. (diff | hist) 03:46 High-performance liquid chromatography 2,620 +491 Retention_Time_Rae (talk | contribs) state the column chemistry and the gradient the figure was obtained on [rollback]
  5. (diff | hist) m 03:02 Peptide synthesis 2,036 ±0 StopperingSteff (talk | contribs) add category for logistics [rollback]

9 July 2024

  1. (diff | hist) 19:14 Wuhan Wansheng Biotechnology 2,861 +1,097 BlankVialBo (talk | contribs) correct the trading name — the short code and the legal name are different things [rollback]
  2. (diff | hist) 16:43 Proglucagon 1,868 +372 TrialsTabitha (talk | contribs) add category for receptor pharmacology [rollback]
  3. (diff | hist) m 09:47 Bacteriostatic water 1,850 ±0 MicrodoseMagnus (talk | contribs) add the disclaimer that this is not administration guidance [rollback]
  4. (diff | hist) N 09:00 Fmoc chemistry 1,514 +1,514 RepackRadek (talk | contribs) create article — process stub
  5. (diff | hist) 07:37 Retatrutide 2,390 ±0 OralSemaOswin (talk | contribs) give the isoelectric point with the method it was determined by [rollback]
  6. (diff | hist) m b 03:47 Adverse effects of GLP-1 receptor agonists 2,045 +733 ArchiveBot (talk | contribs) bot: sort category members [rollback]

8 July 2024

  1. (diff | hist) N 09:00 Proglucagon 1,496 +1,496 Chromatokid (talk | contribs) new article: incretin physiology, expansion welcome
  2. (diff | hist) m 08:11 Dipeptidyl peptidase-4 2,323 ±0 DrTitration (talk | contribs) clarify that the incretin effect is defined by the oral–intravenous comparison [rollback]
  3. (diff | hist) 00:10 Karl Fischer titration 1,651 ±0 GradientGus (talk | contribs) clarify the difference between related substances and total impurities [rollback]

7 July 2024

  1. (diff | hist) 23:11 Incretin effect 2,353 +512 ProglucagonPia (talk | contribs) rm the sentence implying the hormone is a drug [rollback]